Corbus Pharma (CRBP) Misses Q1 EPS by 2c

Corbus Pharma (NASDAQ: CRBP) reported Q1 EPS of ($0.08), $0.02 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $396.6 thousand, versus $0 reported last year.

For earnings history and earnings-related data on Corbus Pharma (CRBP) click here.

You May Also Be Interested In

• Corbus Pharmaceuticals (CRBP) PT Lowered to $52 at Oppenheimer
• SanDisk and Micron surge as Apple confirms memory price pass-through
• JPMorgan Upgrades SHIFT UP Corp (462870:KS) to Overweight